Low-dose anti-aging drug improves brain blood flow in at-risk adults
In short
- Four weeks of low-dose rapamycin improved brain blood flow in healthy middle-aged adults.
- The participants carried APOE4, a gene variant linked to higher Alzheimer's risk.
- Women showed the strongest benefits, according to the study's findings.
Why it's good news
Declining blood flow can occur years before Alzheimer's symptoms begin, so improving it early could matter. This study reports a short, four-week trial in people without symptoms, and it does not show the drug prevents or delays the disease. Further research would be needed before anyone could expect a preventive benefit.
From ScienceDaily
A surprising new study suggests that an anti-aging drug could help protect people genetically predisposed to Alzheimer's disease. Researchers found that just four weeks of low-dose rapamycin improved brain blood flow in healthy middle-aged adults carrying the high-risk APOE4 gene variant, with women showing the strongest benefits. Because declining blood flow can occur years before Alzheimer's symptoms appear, the discovery raises hopes for preventing or delaying the disease before memory loss begins.